Jump to Navigation

Publicaties 2007

Publicaties 2007:

  • Biemond BJ, Perzborn E, Friederich PW, Levi M, Buetehorn U, Buller HR. Prevention and treatment of experimental thrombosis in rabbits with rivaroxaban (BAY 597939) - an oral, direct factor Xa inhibitor. THROMB HAEMOSTASIS 2007;97(3):471-477.     [ PubMed ]

 

  • Bilgin YM, van de Watering LMG, Eijsman L, Versteegh MIM, van Oers MHJ, Brand A. Is increased mortality associated with post-operative infections after leukocytes containing red blood cell transfusions in cardiac surgery? An extended analysis. TRANSFUSION MED 2007;17(4):304-311.     [ PubMed ]

 

  • Bouw J, Kater AP, van Tongeren J, Schultz MJ. Upper-airway obstruction instigated by Sweet's syndrome. MED SCI MONITOR 2007;13(4):CS53-CS55.     [ PubMed ]

 

  • Cheson BD, Pfistner B, Juweid ME, Gascoyne RD, Specht L, Horning SJ, Coiffier B, Fisher RI, Hagenbeek A, Zucca E, Rosen ST, Stroobants S, Lister TA, Hoppe RT, Dreyling M, Tobinai K, Vose JM, Connors JM, Federico M, Diehl V. Revised response criteria for malignant lymphoma. J CLIN ONCOL 2007;25(5):579-586.     [ PubMed ]

 

  • Cornelissen JJ, van Putten WLJ, Verdonck LF, Theobald M, Jacky E, Daenen SMG, Kooy MVM, Wijermans P, Schouten H, Huijgens PC, van der Lelie H, Fey M, Ferrant A, Maertens J, Gratwohl A, Lowenberg B. Results of a HOVON/SAKK donor versus no-donor analysis of myeloablative HLA-identical sibling stem cell



  • transplantation in first remission acute myeloid leukemia in young and middle-aged adults: benefits for whom?. BLOOD 2007;109(9):3658-3666.  

 

  • Daniels G, Flegel WA, Fletcher A, Garratty G, Levene C, Lomas-Francis C, Moulds JM, Moulds JJ, Olsson ML, Overbeeke MAM, Poole J, Reid ME, Rouger P, van der Schoot CE, Scott M, Sistonen P, Smart E, Storry JR, Tani Y, Yu LC, Wendel S, Westhoff CM, Zelinski T. International Society of Blood Transfusion Committee on Terminology for Red Cell Surface Antigens: Cape Town report. VOX SANG 2007;92(3):250-253.     [ PubMed ]

 

  • Daniels G, van der Schoot CE, Olsson ML. Report of the Second International Workshop on molecular blood group genotyping. VOX SANG 2007;93(1):83-88.     [ PubMed ]

 

  • de Heer K, Silbermann MH, Koene HR, Biemond BJ, Muller HP, van Oers MHJ. Systematische diagnostiek van erytrocytose. NED TIJDSCHR GENEESKD 2007;151(32):1770-1776.     [ PubMed ]

 

  • de Jong D, Rosenwald A, Chhanabhai M, Gaulard P, Klapper W, Lee A, Sander B, Thorns C, Campo E, Molina T, Norton A, Hagenbeek A, Horning S, Lister A, Raemaekers J, Gascoyne RD, Salles G, Weller E. Immunohistochemical prognostic markers in diffuse large B-cell lymphoma: Validation of tissue microarray as a prerequisite for broad clinical applications - A study from the Lunenburg Lymphoma Biomarker Consortium. J CLIN ONCOL 2007;25(7):805-812.     [ PubMed ]

 

  • Fermé C, Eghbali H, Meerwaldt JH, Rieux C, Bosq J, Berger F, Girinsky T, Brice P, van't Veer MB, Walewski JA, Lederlin P, Tirelli U, Carde P, van den Neste E, Gyan E, Monconduit M, Diviné M, Raemaekers JMM, Salles G, Noordijk EM, Creemers GJ, Gabarre J, Hagenbeek A, Reman O, Blanc M, Thomas J, Vié B, Kluin-Nelemans JC, Viseu F, Baars JW, Poortmans P, Lugtenburg PJ, Carrie C, Jaubert J, Henry-Amar M. Chemotherapy plus involved-field radiation in early-stage Hodgkin's disease. NEW ENGL J MED 2007;357(19):1916-1927.     [ PubMed ]

 

  • Glas AM, Knoops L, Delahaye L, Kersten MJ, Kibbelaar RE, Wessels LA, van Laar R, van Krieken JHJM, Baars JW, Raemaekers J, Kluin PM, van 't Veer LJ, de Jong D. Gene-expression and immunohistochemical study of specific T-cell subsets and accessory cell types in the transformation and prognosis of follicular lymphoma. J CLIN ONCOL 2007;25(4):390-398.  

 

  • Hallaert DYH, Spijker R, Jak M, Derks IAM, Alves NL, Wensveen FM, de Boer JP, de Jong D, Green SR, van Oers MHJ, Eldering E. Crosstalk among Bcl-2 family members in B-CLL: seliciclib acts via the Mcl-1/Noxa axis and gradual exhaustion of Bcl-2 protection. CELL DEATH DIFFER 2007;14(11):1958-1967.     [ PubMed ]

 

  • Kater A, Henke MO, Rubin BK. The role of DNA and actin polymers on the polymer structure and rheology of cystic fibrosis sputum and depolymerization by gelsolin or thymosin beta 4. ANN NY ACAD SCI 2007;1112:140-153.     [ PubMed ]

 

  • Kater AP, van Oers MHJ, Kipps TJ. Cellular immune therapy for chronic lymphocytic leukemia. BLOOD 2007;110(8):2811-2818.     [ PubMed ]

 

  • Kerst JM, Heisterkamp S, de Jong D, Haas RLM, Kersten MJ. Nieuwe ontwikkelingen in de diagnostiek en primaire behandeling van indolent folliculair non-hodgkinlymfoom. NED TIJDSCHR HEMATOL 2007;4(7):244-250.  

 

  • Klein SK, Biemond BJ, van Oers MHJ. Two cases of isolated symptomatic myocarditis induced by all-trans retinoic acid (ATRA). ANN HEMATOL 2007;86(12):917-918.     [ PubMed ]

 

  • Klein SK, Kersten MJ. Rituximab: standaardtherapie bij non-Hodgkin lymfoom. TIJDSCHR KANKER 2007;31:20.  

 

  • Koene HR. Nieuwe behandelmethoden voor auto-immuuntrombocytopenie. NED TIJDSCHR GENEESKD 2007;151(47):2609-2614.     [ PubMed ]

 

  • Koene HR, Biemond BJ, van der Schoot CE. Van gen naar ziekte; JAK2 en polycythaemia vera. NED TIJDSCHR GENEESKD 2007;151(32):1784-1787.     [ PubMed ]

 

  • Kremer Hovinga JA, Zeerleder S, Kessler P, Romani de Wit T, van Mourik JA, Hack CE, ten Cate H, Reitsma PH, Wuillemin WA, Lämmle B. ADAMTS-13, von Willebrand factor and related parameters in severe sepsis and septic shock. J THROMB HAEMOST 2007;5(11):2284-2290.     [ PubMed ]

 

  • Legler TJ, Liu Z, Mavrou A, Finning K, Hromadnikova I, Galbiati S, Meaney C, Hultén MA, Crea F, Olsson ML, Maddocks DG, Huang D, Fisher SA, Sprenger-Haussels M, Soussan AA, van der Schoot CE. Workshop report on the extraction of foetal DNA from maternal plasma. PRENATAL DIAG 2007;27(9):824-829.     [ PubMed ]

 

  • Macaulay IC, Tijssen MR, Thijssen-Timmer DC, Gusnanto A, Steward M, Burns P, Langford CF, Ellis PD, Dudbridge F, Zwaginga JJ, Watkins NA, van der Schoot CE, Ouwehand WH. Comparative gene expression profiling of in vitro differentiated megakaryocytes and erythroblasts identifies novel activatory and inhibitory platelet membrane proteins. BLOOD 2007;109(8):3260-3269.     [ PubMed ]

 

  • Marcus R, Hagenbeek A. The therapeutic use of rituximab in non-Hodgkin's lymphoma. EUR J HAEMATOL 2007;78(Suppl. 67):5-14.     [ PubMed ]

 

  • Niers TMH, Di Nisio M, Klerk CPW, Baarslag HJ, Bueller HR, Biemond BJ. Prevention of catheter-related venous thrombosis with nadroparin in patients receiving chemotherapy for hematologic malignancies: a randomized, placebo-controlled study. J THROMB HAEMOST 2007;5(9):1878-1882.     [ PubMed ]

 

  • Rijneveld AW, Koene HR, Kersten MJ. Maligne lymfomen bij patienten met een hiv-infectie. TIJDSCHR INFECTIEZIEKTEN 2007;2(6):202-208.  

 

  • Rijneveld AW, Koene HR, Kersten MJ. Maligne lymfomen bij patienten met immuundeficientie ten gevolge van een hiv-infectie. NED TIJDSCHR HEMATOL 2007;4(6):204-209.  

 

  • Smit LA, Hallaert DYH, Spijker R, de Goeij B, Jaspers A, Kater AP, van Oers MHJ, van Noesel CJM, Eldering E. Differential Noxa/Mcl-1 balance in peripheral versus lymph node chronic lymphocytic leukemia cells correlates with survival capacity. BLOOD 2007;109(4):1660-1668.     [ PubMed ]

 

  • Sonneveld P, van der Holt B, Segeren CM, Vellenga E, Croockewit AJ, Verhoe GEG, Cornelissen JJ, Schaafsma MR, van Oers MHJ, Wijermans PW, Westveer PHM, Lokhorst HM. Intermediate-dose melphalan compared with myeloablative treatment in multiple myeloma: long-term follow-up of the Dutch Cooperative Group HOVON 24 trial. HAEMATOL-HEMATOL J 2007;92(7):928-935.     [ PubMed ]

 

  • Stone R, Potting CMJ, Clare S, Uhlenhopp M, Davies M, Mank A, Quinn B. Management of oral mucositis at European transplantation centres. EUR J ONCOL NURS 2007;11(Suppl. 1):S3-S9.     [ PubMed ]

 

  • van Beers EJ, van Tuijn CFJ, Nieuwkerk PT, Friederich PW, Vranken JH, Biemond BJ. Patient-controlled analgesia versus continuous infusion of morphine during vaso-occlusive crisis in sickle cell disease, a randomized controlled trial. AM J HEMATOL 2007;82(11):955-960.     [ PubMed ]

 

  • van der Velden VHJ, Cazzaniga G, Schrauder A, Hancock J, Bader P, Panzer-Grumayer ER, Flohr T, Sutton R, Cave H, Madsen HO, Cayuela JM, Trka J, Eckert C, Foroni L, Zur Stadt U, Beldjord K, Raff T, van der Schoot CE, van Dongen JJM. Analysis of minimal residual disease by Ig/TCR gene rearrangements: guidelines for interpretation of real-time quantitative PCR data. LEUKEMIA 2007;21(4):604-611.     [ PubMed ]

 

  • van Oers MHJ. Rituximab maintenance in indolent lymphoma: indications and controversies. CURR ONCOL REP 2007;9(5):378-383.     [ PubMed ]

 

  • van Oers MHJ. Rituximab maintenance therapy: a step forward in follicular lymphoma. HAEMATOL-HEMATOL J 2007;92(6):826-833.     [ PubMed ]

 

  • van Oosterwijk MF, Juwana H, Arens R, Tesselaar K, van Oers MHJ, Eldering E, van Lier RAW. CD27-CD70 interactions sensitise naive CD4+ T cells for IL-12-induced Th1 cell development. INT IMMUNOL 2007;19(6):713-718.     [ PubMed ]

 

  • van Rijn RS, Simonetti ER, Hagenbeek A, Bonyhadi M, Storm G, Martens ACM, Ebeling SB. Quantitative assessment of human T lymphocytes in RAG2(-/-)gammac(-/-) mice: the impact of ex vivo manipulation on in vivo functionality. EXP HEMATOL 2007;35(1):117-127.     [ PubMed ]

 

  • Vermeulen M, van Oers MHJ. Relapse of chronic inflammatory demyelinating polyneuropathy 5 years after autologous stem cell transplantation. J NEUROL NEUROSUR PS 2007;78(10):1154.     [ PubMed ]

 

  • Winter N, Mank A, Lommerse E. Het belang van goede handhygiëne. ONCOLOGICA 2007;24(1):24-27.  

 

  • Zeerleder SS. Studies on inflammatory and coagulation pathways in humans with sepsis. s.l.: s.n.; 2007. (142pp.) (ISBN 9090214070) (PhD thesis. Supervisor(s):  Hack CE, Wuillemin WA) [ UvA Dissertations Online ]

 

  • Zeerleder S, Schroeder V, Lämmle B, Wuillemin WA, Hack CE, Kohler HP. Factor XIII in severe sepsis and septic shock. THROMB RES 2007;119(3):311-318.     [ PubMed ]

 

  • Zeerleder S, Zwart B, te Veldhuis H, Manoe R, Bulder I, Rensink I, Aarden LA. A plasma nucleosome releasing factor (NRF) with serine protease activity is instrumental in removal of nucleosomes from secondary necrotic cells. FEBS LETT 2007;581(28):5382-5388.     [ PubMed ]

 

Auteur: B.M.J.M. Odijk, versie: 1, 19-03-2019